1. Home
  2. ELV vs CSCI Comparison

ELV vs CSCI Comparison

Compare ELV & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELV
  • CSCI
  • Stock Information
  • Founded
  • ELV 1944
  • CSCI 1990
  • Country
  • ELV United States
  • CSCI Canada
  • Employees
  • ELV N/A
  • CSCI N/A
  • Industry
  • ELV Medical Specialities
  • CSCI
  • Sector
  • ELV Health Care
  • CSCI
  • Exchange
  • ELV Nasdaq
  • CSCI NYSE
  • Market Cap
  • ELV N/A
  • CSCI 9.9M
  • IPO Year
  • ELV N/A
  • CSCI 1996
  • Fundamental
  • Price
  • ELV $403.56
  • CSCI $3.50
  • Analyst Decision
  • ELV Buy
  • CSCI
  • Analyst Count
  • ELV 15
  • CSCI 0
  • Target Price
  • ELV $519.76
  • CSCI N/A
  • AVG Volume (30 Days)
  • ELV 1.4M
  • CSCI 3.5K
  • Earning Date
  • ELV 04-22-2025
  • CSCI 05-20-2025
  • Dividend Yield
  • ELV 1.66%
  • CSCI N/A
  • EPS Growth
  • ELV N/A
  • CSCI N/A
  • EPS
  • ELV 25.60
  • CSCI N/A
  • Revenue
  • ELV $183,124,000,000.00
  • CSCI $9,587,000.00
  • Revenue This Year
  • ELV $11.06
  • CSCI N/A
  • Revenue Next Year
  • ELV $7.16
  • CSCI N/A
  • P/E Ratio
  • ELV $16.11
  • CSCI N/A
  • Revenue Growth
  • ELV 6.63
  • CSCI 34.22
  • 52 Week Low
  • ELV $362.21
  • CSCI $1.96
  • 52 Week High
  • ELV $567.26
  • CSCI $11.10
  • Technical
  • Relative Strength Index (RSI)
  • ELV 41.09
  • CSCI N/A
  • Support Level
  • ELV $406.55
  • CSCI N/A
  • Resistance Level
  • ELV $419.99
  • CSCI N/A
  • Average True Range (ATR)
  • ELV 10.60
  • CSCI 0.00
  • MACD
  • ELV -1.50
  • CSCI 0.00
  • Stochastic Oscillator
  • ELV 8.35
  • CSCI 0.00

About CSCI COSCIENS BIOPHARMA INC

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

Share on Social Networks: